Defeating migraine pain with triptans: A race against the development of cutaneous allodynia
By R. Burstein, B. Collins, M. Jakubowski. Annals of Neurology, 2004
603 citations recorded by the source corpus.
Subfields: Physiology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/55ea1657a64c1496210cd28abe4427028271bd86
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Physiology
In Psychiatry and Mental health
Citations in the corpus
- EFNS guideline on the drug treatment of migraine – revised report of an EFNS task force (2009, background): “cious or even may fail when taken after the onset of allodynia during a migraine attack [49,53], with ran-”
- Pathophysiology of Migraine: A Disorder of Sensory Processing. (2017, background): “It can also extend to extracephalic regions, and become an allover body allodynia, such as during dressing (127, 128).”
- Acute Migraine Medications and Evolution From Episodic to Chronic Migraine: A Longitudinal Population‐Based Study (2008, background): “It has been suggested that individuals with central sensitization respond poorly to tritpans but not to NSAIDs.33,34 Perhaps drugs that directly address migraine-related inflammation may prevent or reverse central sensitization and the risk of TM.”